Rohr Eye and Laser Center Rohr Eye and Laser Center

Now there is an answer for millions that suffer from dry eye. There are nearly 30 million people in the United States and over 300 million worldwide who have been diagnosed with dry eye. Most have learned to live with eye discomfort and have become dependent on drops or other treatment methods that only offer temporary relief. This has been due to a lack of understanding that the root cause of most dry eye is now known to be a chronic and progressive condition, Meibomian Gland Dysfunction or MGD.

MGD occurs when there are blockages or structural damage that inhibits the natural production of protective oils from the Meibomian glands located in our eyelids. This oil protects the watery layer in our tear film, but when these oils are not present, it causes your tears to rapidly evaporate and lose their consistency. Without these oils our eyes become more susceptible to the negative effects that dry climates, air conditioning, computer use, reading and other daily activities can have on the long-term health of our eyes.

Treating MGD with LipiFlow®

While there are multiple choices available for treating MGD, LipiFlow is the only is FDA-cleared device for removing gland blockages and restoring gland function. Through advances in the application of Vectored Thermal Pulsation (VTP™) technology, the LipiFlow treatment utilizes a patented algorithm of warmth applied to the inner eyelids and massage to remove the obstructions in your Meibomian glands.